Home
This Title All WIREs
WIREs RSS Feed
How to cite this WIREs title:
WIREs Syst Biol Med
Impact Factor: 3.676

Systems biology and the future of medicine

Full article on Wiley Online Library:   HTML PDF

Can't access this content? Tell your librarian.

Contemporary views of human disease are based on simple correlation between clinical syndromes and pathological analysis dating from the late 19th century. Although this approach to disease diagnosis, prognosis, and treatment has served the medical establishment and society well for many years, it has serious shortcomings for the modern era of the genomic medicine that stem from its reliance on reductionist principles of experimentation and analysis. Quantitative, holistic systems biology applied to human disease offers a unique approach for diagnosing established disease, defining disease predilection, and developing individualized (personalized) treatment strategies that can take full advantage of modern molecular pathobiology and the comprehensive data sets that are rapidly becoming available for populations and individuals. In this way, systems pathobiology offers the promise of redefining our approach to disease and the field of medicine. WIREs Syst Biol Med 2011 3 619–627 DOI: 10.1002/wsbm.144

This WIREs title offers downloadable PowerPoint presentations of figures for non-profit, educational use, provided the content is not modified and full credit is given to the author and publication.

Download a PowerPoint presentation of all images


Figure 1.

The human systems biology universe. Human systems comprise molecular and phenotypic networks, which are related to, but distinct from, each other, as indicated by the separate linked ovals. The human disease‐ome represents a collection of subnetworks, the disease modules, which are identified by one of two strategies, the molecular network‐based strategy or the functional and structural similarity‐based strategy. The assembly of disease modules into the disease‐ome can be determined by bioinformatics‐based approaches—the shared gene formalism, the shared metabolic pathway formalism, or the disease comorbidity formalism—or by laboratory‐based experimentation.

[ Normal View | Magnified View ]

Browse by Topic

Translational, Genomic and Systems Medicine > Translational Medicine
blog comments powered by Disqus

Access to this WIREs title is by subscription only.

Recommend to Your
Librarian Now!

The latest WIREs articles in your inbox

Sign Up for Article Alerts

In the Spotlight

William J. Pavan

William J. Pavan

is interested in using genomic tools to understand how an embryo develops into a functioning organism. His group focuses on neural crest cells, a group of stem cells that differentiate into a wide variety of tissues in the bodys. Issues with the development of the neural crest cells can cause many diseases, ranging from Waardenburg syndrome to cleft lip and palate. Using genomic research tools, Dr. Pavan seeks to identify the genes necessary for normal neural crest cell development, specifically the ones which differentiate into melanocytes. At least 15 genes have been recognized as important in the development of neural crest cells, but there are likely hundreds of genes involved in total. Dr. Pavan’s lab often uses the models of neural crest cell disorders in mice in order to identify the genes needed for normal development. They then study how these genes function, and whether there are corresponding genes in humans that can cause human diseases.

Learn More

Twitter: WIREsSysBioMed Follow us on Twitter